Masayoshi Takeuchi

Hokuriku University

Papers

1

Total Citations

53

H-Index

1

About

Masayoshi Takeuchi is a leading figure in diabetes research, with a primary focus on the molecular mechanisms driving diabetic complications, particularly nephropathy. His work has been instrumental in elucidating the pathological role of advanced glycation end products (AGEs) and their downstream effects on kidney function. In his highly cited 2004 study (53 citations), Takeuchi demonstrated that AGEs increase the expression of HSP47, a collagen-specific chaperone, in a mouse model of diabetic nephropathy. This finding was pivotal, as it linked AGE accumulation directly to the fibrotic processes that characterize kidney damage in diabetes. Furthermore, his research explored the therapeutic potential of OPB-9195, an AGE formation inhibitor, highlighting a promising strategy to mitigate these harmful effects. Takeuchi’s contributions have not only deepened our understanding of diabetic kidney disease but have also opened new avenues for targeted therapies. His work remains a cornerstone for researchers investigating the intersection of protein glycation, cellular stress responses, and chronic diabetic complications, making him a respected authority in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
53
Total Citations
53
Avg Citations/Paper
🏆 Most Cited Paper
Advanced Glycation End Products Increase Collagen-specific Chaperone Protein in Mouse Diabetic Nephropathy
53 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Hokuriku University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago